1998
DOI: 10.1002/(sici)1097-0215(19980812)77:4<554::aid-ijc14>3.0.co;2-6
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of theNF2 gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
40
0

Year Published

2001
2001
2008
2008

Publication Types

Select...
4
3

Relationship

3
4

Authors

Journals

citations
Cited by 52 publications
(44 citation statements)
references
References 22 publications
4
40
0
Order By: Relevance
“…The tumour suppressor gene, NF2, has been found to be frequently inactivated in mesothelioma (Bianchi et al, 1995;Sekido et al, 1995;Deguen et al, 1998), indicating that the deregulation of the NF2 pathway can be involved in the neoplastic transformation of mesothelial cells. Mesothelioma is not a characteristic feature of NF2 patients, but one case of peritoneal mesothelioma in an NF2 patient exposed to asbestos has been recently reported (Baser et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The tumour suppressor gene, NF2, has been found to be frequently inactivated in mesothelioma (Bianchi et al, 1995;Sekido et al, 1995;Deguen et al, 1998), indicating that the deregulation of the NF2 pathway can be involved in the neoplastic transformation of mesothelial cells. Mesothelioma is not a characteristic feature of NF2 patients, but one case of peritoneal mesothelioma in an NF2 patient exposed to asbestos has been recently reported (Baser et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Positive controls for NF2 expression studies were total protein extracts from WT or Nf2 KO3/ þ mouse brain, whereas total protein extracts from a human mesothelioma cell line, CORO, established in the laboratory (Deguen et al, 1998), were used as negative control.…”
Section: Western Blot and Immunoprecipitation Analysesmentioning
confidence: 99%
“…12 and references therein). Mutations that lead to the skipping of exon 3 (Sch⌬81-121) or exons 2-3 (Sch⌬39 -121) have been observed in the germ line or in the tumors of the NF2 patients (12,18,19). These mutations impair the proper folding of the schwannomin FERM domain (7).…”
Section: Neurofibromatosis Type 2 (Nf2)mentioning
confidence: 99%
“…In human tumors, levels of mutant Sch are consistently below limits of detection although NF2 mutant alleles were detected at the mRNA level (12)(13)(14)(15). Therefore, we reasoned that mutant schwannomin might be degraded quickly.…”
Section: Neurofibromatosis Type 2 (Nf2)mentioning
confidence: 99%
See 1 more Smart Citation